Home / Germany / AnaptysBio, Inc.
AnaptysBio, Inc.
Short position disclosed on February 7, 2018.
0.59% of the capital sold short
1 disclosing fund
3 disclosures on record
US0327241065 ISIN code
Evolution of the disclosed total
0%0.2%0.4%0.6%
Oct 2025Jan 2026Apr 2026Jul 2026
January 24, 2018 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| PDT Partners, LLC | 0.59% | unchanged | February 7, 2018 |
In the United States ANAB (Nasdaq): 5,412,436 shares sold short on August 31, 2026. FINRA names no fund.
On the other side: the funds that hold AnaptysBio, Inc. Titelia
Get the moves on AnaptysBio, Inc. by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| February 7, 2018 | PDT Partners, LLC | 0.59% | still open |
| January 25, 2018 | PDT Partners, LLC | 0.68% | |
| January 24, 2018 | PDT Partners, LLC | 0.70% |
Download 3 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Germany
- TUI AG 8.56% of the capital sold short
- HelloFresh SE 7.84% of the capital sold short
- AUTO1 Group SE 7.23% of the capital sold short
- Hugo Boss AG 7.19% of the capital sold short
- Zalando SE 6.11% of the capital sold short
- Gerresheimer AG 5.99% of the capital sold short
- PVA TePla AG 5.72% of the capital sold short
- Velo3D Inc 5.72% of the capital sold short
- Cancom SE 5.55% of the capital sold short
- Puma SE 5.41% of the capital sold short
- RENK Group AG 5.31% of the capital sold short
- TAG Immobilien AG 5.19% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, AnaptysBio, Inc., source Bundesanzeiger, data as at February 7, 2018, https://www.quivad.com/action/anaptysbio-inc